vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and PROCORE TECHNOLOGIES, INC. (PCOR). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $349.1M, roughly 1.4× PROCORE TECHNOLOGIES, INC.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -10.8%, a 17.6% gap on every dollar of revenue. On growth, PROCORE TECHNOLOGIES, INC. posted the faster year-over-year revenue change (15.6% vs -1.7%). Over the past eight quarters, PROCORE TECHNOLOGIES, INC.'s revenue compounded faster (13.8% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling.
MD vs PCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $349.1M |
| Net Profit | $33.7M | $-37.6M |
| Gross Margin | — | 80.1% |
| Operating Margin | 9.9% | -12.3% |
| Net Margin | 6.8% | -10.8% |
| Revenue YoY | -1.7% | 15.6% |
| Net Profit YoY | 10.5% | 39.6% |
| EPS (diluted) | $0.40 | $-0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $349.1M | ||
| Q3 25 | $492.9M | $338.9M | ||
| Q2 25 | $468.8M | $323.9M | ||
| Q1 25 | $458.4M | $310.6M | ||
| Q4 24 | $502.4M | $302.0M | ||
| Q3 24 | $511.2M | $295.9M | ||
| Q2 24 | $504.3M | $284.3M | ||
| Q1 24 | $495.1M | $269.4M |
| Q4 25 | $33.7M | $-37.6M | ||
| Q3 25 | $71.7M | $-9.1M | ||
| Q2 25 | $39.3M | $-21.1M | ||
| Q1 25 | $20.7M | $-33.0M | ||
| Q4 24 | $30.5M | $-62.3M | ||
| Q3 24 | $19.4M | $-26.4M | ||
| Q2 24 | $-153.0M | $-6.3M | ||
| Q1 24 | $4.0M | $-11.0M |
| Q4 25 | — | 80.1% | ||
| Q3 25 | — | 79.7% | ||
| Q2 25 | — | 79.1% | ||
| Q1 25 | — | 79.1% | ||
| Q4 24 | — | 81.2% | ||
| Q3 24 | — | 81.4% | ||
| Q2 24 | — | 83.1% | ||
| Q1 24 | — | 83.0% |
| Q4 25 | 9.9% | -12.3% | ||
| Q3 25 | 13.8% | -4.4% | ||
| Q2 25 | 12.8% | -9.3% | ||
| Q1 25 | 7.0% | -11.7% | ||
| Q4 24 | 7.8% | -21.9% | ||
| Q3 24 | 6.6% | -12.3% | ||
| Q2 24 | -31.3% | -5.2% | ||
| Q1 24 | 3.2% | -7.0% |
| Q4 25 | 6.8% | -10.8% | ||
| Q3 25 | 14.5% | -2.7% | ||
| Q2 25 | 8.4% | -6.5% | ||
| Q1 25 | 4.5% | -10.6% | ||
| Q4 24 | 6.1% | -20.6% | ||
| Q3 24 | 3.8% | -8.9% | ||
| Q2 24 | -30.3% | -2.2% | ||
| Q1 24 | 0.8% | -4.1% |
| Q4 25 | $0.40 | $-0.25 | ||
| Q3 25 | $0.84 | $-0.06 | ||
| Q2 25 | $0.46 | $-0.14 | ||
| Q1 25 | $0.24 | $-0.22 | ||
| Q4 24 | $0.37 | $-0.42 | ||
| Q3 24 | $0.23 | $-0.18 | ||
| Q2 24 | $-1.84 | $-0.04 | ||
| Q1 24 | $0.05 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $768.5M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $1.3B |
| Total Assets | $2.2B | $2.2B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $768.5M | ||
| Q3 25 | $340.1M | $684.0M | ||
| Q2 25 | $224.7M | $620.9M | ||
| Q1 25 | $99.0M | $566.7M | ||
| Q4 24 | $229.9M | $775.4M | ||
| Q3 24 | $103.8M | $756.9M | ||
| Q2 24 | $19.4M | $735.4M | ||
| Q1 24 | $8.0M | $744.6M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.3B | ||
| Q3 25 | $890.7M | $1.2B | ||
| Q2 25 | $833.8M | $1.2B | ||
| Q1 25 | $789.2M | $1.2B | ||
| Q4 24 | $764.9M | $1.3B | ||
| Q3 24 | $732.5M | $1.3B | ||
| Q2 24 | $706.5M | $1.3B | ||
| Q1 24 | $856.2M | $1.2B |
| Q4 25 | $2.2B | $2.2B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $2.1B | $2.0B | ||
| Q1 25 | $2.0B | $1.9B | ||
| Q4 24 | $2.2B | $2.1B | ||
| Q3 24 | $2.1B | $2.0B | ||
| Q2 24 | $2.0B | $2.0B | ||
| Q1 24 | $2.2B | $1.9B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $114.9M |
| Free Cash FlowOCF − Capex | — | $109.2M |
| FCF MarginFCF / Revenue | — | 31.3% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $282.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $114.9M | ||
| Q3 25 | $137.3M | $88.5M | ||
| Q2 25 | $137.2M | $30.8M | ||
| Q1 25 | $-117.5M | $66.0M | ||
| Q4 24 | $133.0M | $29.1M | ||
| Q3 24 | $91.8M | $39.3M | ||
| Q2 24 | $107.0M | $58.7M | ||
| Q1 24 | $-125.2M | $69.1M |
| Q4 25 | — | $109.2M | ||
| Q3 25 | — | $83.1M | ||
| Q2 25 | — | $27.9M | ||
| Q1 25 | — | $62.0M | ||
| Q4 24 | — | $17.4M | ||
| Q3 24 | — | $35.7M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | — | $67.1M |
| Q4 25 | — | 31.3% | ||
| Q3 25 | — | 24.5% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | — | 20.0% | ||
| Q1 24 | — | 24.9% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PCOR
| US | $298.3M | 85% |
| Non Us | $50.9M | 15% |
